These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33412226)

  • 21. Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors.
    Esser-Nobis K; Hatfield LD; Gale M
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15778-15788. PubMed ID: 32571931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of antiviral innate immune signaling by stress-induced RNA granules.
    Yoneyama M; Jogi M; Onomoto K
    J Biochem; 2016 Mar; 159(3):279-86. PubMed ID: 26748340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response.
    Ferreira AR; Magalhães AC; Camões F; Gouveia A; Vieira M; Kagan JC; Ribeiro D
    J Cell Mol Med; 2016 Apr; 20(4):750-7. PubMed ID: 26865163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon induction by RNA viruses and antagonism by viral pathogens.
    Nan Y; Nan G; Zhang YJ
    Viruses; 2014 Dec; 6(12):4999-5027. PubMed ID: 25514371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion.
    Jensen S; Thomsen AR
    J Virol; 2012 Mar; 86(6):2900-10. PubMed ID: 22258243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyruvate Carboxylase Activates the RIG-I-like Receptor-Mediated Antiviral Immune Response by Targeting the MAVS signalosome.
    Cao Z; Zhou Y; Zhu S; Feng J; Chen X; Liu S; Peng N; Yang X; Xu G; Zhu Y
    Sci Rep; 2016 Feb; 6():22002. PubMed ID: 26906558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying RNA Sensors in Antiviral Innate Immunity.
    Zheng C; Zhang L
    Methods Mol Biol; 2025; 2854():107-115. PubMed ID: 39192123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How Dengue Virus Circumvents Innate Immunity.
    Kao YT; Lai MMC; Yu CY
    Front Immunol; 2018; 9():2860. PubMed ID: 30564245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mitochondrial protein ERAL1 suppresses RNA virus infection by facilitating RIG-I-like receptor signaling.
    Li S; Kuang M; Chen L; Li Y; Liu S; Du H; Cao L; You F
    Cell Rep; 2021 Jan; 34(3):108631. PubMed ID: 33472079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of host inflammasomes to viral infection.
    Chen IY; Ichinohe T
    Trends Microbiol; 2015 Jan; 23(1):55-63. PubMed ID: 25456015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling.
    Koshiba T; Yasukawa K; Yanagi Y; Kawabata S
    Sci Signal; 2011 Feb; 4(158):ra7. PubMed ID: 21285412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammasomes on the Crossroads of Innate Immune Recognition and Metabolic Control.
    Próchnicki T; Latz E
    Cell Metab; 2017 Jul; 26(1):71-93. PubMed ID: 28683296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAC1 Potentiates Cellular Antiviral Signaling by Bridging MAVS and TBK1.
    Xia Z; Xu G; Nie L; Liu L; Peng N; He Q; Zuo Q; Zhou Y; Cao Z; Liu S; Zhu Y
    J Immunol; 2019 Aug; 203(4):1001-1011. PubMed ID: 31235549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production.
    Wang R; Zhu Y; Lin X; Ren C; Zhao J; Wang F; Gao X; Xiao R; Zhao L; Chen H; Jin M; Ma W; Zhou H
    Autophagy; 2019 Jul; 15(7):1163-1181. PubMed ID: 30741586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The heterogeneous nuclear ribonucleoprotein hnRNPM inhibits RNA virus-triggered innate immunity by antagonizing RNA sensing of RIG-I-like receptors.
    Cao P; Luo WW; Li C; Tong Z; Zheng ZQ; Zhou L; Xiong Y; Li S
    PLoS Pathog; 2019 Aug; 15(8):e1007983. PubMed ID: 31433824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors.
    Onomoto K; Onoguchi K; Yoneyama M
    Cell Mol Immunol; 2021 Mar; 18(3):539-555. PubMed ID: 33462384
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Seo J; Park YS; Kweon TH; Kang J; Son S; Kim HB; Seo YR; Kang MJ; Yi EC; Lee YH; Kim JH; Park B; Yang WH; Cho JW
    Front Immunol; 2020; 11():589259. PubMed ID: 33603735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
    Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.